CAMPBELL, Calif.–Saama Technologies, the #1 AI-powered clinical analytics company, will participate in the Morgan Stanley 19th Annual Global Healthcare Conference on Friday, September 10. Company Founder and CEO Suresh Katta will discuss disruptive drug development technologies in a session starting at 1:15 p.m. ET.
About Saama Technologies, Inc.
Saama is the #1 AI-driven Intelligent Clinical Cloud company, enabling the life sciences industry to conduct faster and safer clinical development and regulatory programs. Today, over 50 biotech companies use Saama’s award-winning Life Science Analytics Cloud (LSAC) platform on more than 1,500 studies, including many of the top 20 pharmaceutical companies. LSAC’s rich applications facilitate an unprecedented, authoritative oversight of comprehensive clinical research data, enabling companies to file New Drug Applications (NDAs) more efficiently and bring drugs to market faster. Discover more at www.saama.com and follow Saama @SaamaTechInc.
Gregory T. Simpson
Access Out-of-the-Box Features in 4 Weeks—Guaranteed.
Saama can put you on the fast track to clinical trial process innovation.